Search

everythinglearnresearchcommunity

for

Search:↓

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

Polycystic ovarian disease symptoms can continue after menopause, making diagnosis and management in older women challenging.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

Teens with PCOS have a higher risk of type 2 diabetes and need regular glucose checks.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Hair loss is linked to insulin resistance in women, regardless of hormone levels.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Early balding men may have insulin resistance, but lifestyle changes can help.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.